Prostate Cancer Devices Market Analysis: Growth, Size, Share & Future Trends (2024-2029) 

The market report offers a detailed analysis segmented by Type (Robotic Surgery Devices, External Beam Radiation Therapy (EBRT) Devices, Brachytherapy, High-Intensity Focused Ultrasound (HIFU) Devices, Cryotherapy Devices); by End User (Hospitals, Ambulatory Surgical Centers); by Geography (North America, South America, Asia Pacific, Europe, The Middle East, Africa).

Outlook 

• The prostate cancer devices market is estimated to be at USD 4,957.58 Mn in 2024 and is anticipated to reach USD 8,510.44 Mn in 2029. 

• The prostate cancer devices market is registering a CAGR of 11.41% during the forecast period 2024-2029. 

• The global prostate cancer devices market is driven by the rising prevalence of prostate cancer, coupled with technological advancements in medical devices. Prostate cancer devices have evolved with the introduction of innovative imaging systems and minimally invasive treatment options. 

Request a free sample. 

Ecosystem 

• The participants in the global prostate cancer devices industry are heavily investing in research and development to bring next-generation prostate cancer devices to the market. 

• These companies primarily focus on collaboration between medical device manufacturers and research institutions for driving advancements in prostate cancer treatment, along with mergers and acquisitions to maintain a competitive edge in the market. 

• Several important entities in the prostate cancer devices market include Intuitive Surgical, Inc.; Varian Medical Systems, Inc.; Elekta GmbH; Accuray Inc.; HealthTronics, Inc.; and others. 

Ask for customization. 

Findings 

Attributes	Values
Historical Period	2018-2022
Base Year	2023
Forecast Period	2024-2029
Market Size (2024)	USD 4,957.58 Mn
Market Size (2029)	USD 8,510.44 Mn
Growth Rate	11.41% CAGR from 2024 to 2029
Key Segments	Type (Robotic Surgery Devices, EBRT Devices, Brachytherapy, HIFU Devices, Cryotherapy Devices); End User (Hospitals, Ambulatory Surgical Centers); Geography (North America, South America, Asia Pacific, Europe, The Middle East, Africa)
Key Vendors	Intuitive Surgical, Inc.; Varian Medical Systems, Inc.; Elekta GmbH; Accuray Inc.; HealthTronics, Inc.
Key Countries	The US; Canada; Mexico; Brazil; Argentina; Colombia; Chile; China; India; Japan; South Korea; The UK; Germany; Italy; France; Spain; Turkey; UAE; Saudi Arabia; Egypt; South Africa
Largest Market	North America

Get a free quote. 

Trends  

• Focus on Personalized Medicine: Personalized medicine is gaining traction in the treatment of prostate cancer. By tailoring therapies to individual patients based on their genetic profiles and specific tumor characteristics, doctors can now offer more targeted and effective interventions. In 2023, Philips Healthcare launched a diagnostic device that uses patient-specific data to tailor treatment plans, enabling more precise and effective interventions. 

• Emphasis on Holistic Treatment Approaches: Holistic approaches to prostate cancer care are becoming increasingly popular. These methods combine traditional medical treatments with lifestyle modifications, including diet, exercise, and stress management. In 2023, Mayo Clinic introduced a program combining prostate cancer treatment with nutritional counseling and mental health support, highlighting a shift toward comprehensive patient care. 

• Telemedicine for Post-Surgical Care: Telemedicine is being used to monitor a patient’s post-prostate surgery remotely. Urology Associates partnered with TeleMed Solutions in 2023 to offer remote follow-up care for prostate cancer patients, ensuring timely consultations and reduced hospital visits. 

Speak to analyst. 

Catalysts 

• Rising Incidence of Prostate Cancer: The increasing prevalence of prostate cancer is a key driver of the market. According to Cancer Research UK, over 1.4 million new cases of prostate cancer were diagnosed globally in 2023, leading to a higher demand for diagnostic and therapeutic devices. 

• Advances in Imaging Technology: Technological innovations in imaging devices have significantly improved prostate cancer detection. In 2023, GE Healthcare introduced an advanced MRI-guided biopsy device that enhances accuracy and reduces the risk of misdiagnosis, fueling market demand. 

• Increased Focus on Early Detection and Screening: Growing awareness of early detection and screening methods is driving demand for diagnostic devices. In 2023, Hologic launched a new prostate-specific antigen (PSA) screening tool aimed at improving early cancer diagnosis, which saw widespread adoption in primary healthcare settings. 

Inquire before buying. 

Restraints 

• High Cost of Advanced Devices: The high cost of prostate cancer diagnostic and treatment devices is a significant barrier, particularly in developing regions. In 2023, Boston Scientific reported that the average cost of robotic-assisted surgery devices had increased by 10%, limiting accessibility for low-income patients. 

• Limited Reimbursement Policies: Limited insurance coverage and reimbursement for advanced prostate cancer treatments are deterring patients from opting for high-tech devices. In 2023, a survey conducted by the Prostate Cancer Foundation showed that 35% of patients in the U.S. avoided robotic surgery due to inadequate insurance reimbursement, impacting device adoption. 

• Regulatory Approval Delays: Strict regulatory processes can slow down the approval of new prostate cancer devices. In 2023, Siemens Healthineers faced delays in obtaining Food and Drug Administration (FDA) approval for its new MRI-guided therapy device, delaying its market entry and affecting potential sales. 

Personalize this research. 

Hotspot 

Explore purchase options. 

Table of Contents 

1.       Introduction         1.1.    Research Methodology         1.2.    Scope of the Study  2.       Market Overview / Executive Summary         2.1.    Global Prostate Cancer Devices Market (2018 – 2022)         2.2.    Global Prostate Cancer Devices Market (2023 – 2029)  3.       Market Segmentation         3.1.    Global Prostate Cancer Devices Market by Type                3.1.1.    Robotic Surgery Devices                3.1.2.    EBRT Devices                3.1.3.    Brachytherapy                3.1.4.    HIFU Devices                3.1.5.    Cryotherapy Devices         3.2.    Global Prostate Cancer Devices Market by End User                3.2.1.    Hospitals                3.2.2.    Ambulatory Surgical Centers  4.       Regional Segmentation         4.1.    North America                4.1.1.    The US                4.1.2.    Canada                4.1.3.    Mexico         4.2.    South America                4.2.1.    Brazil                4.2.2.    Argentina                4.2.3.    Colombia                4.2.4.    Chile                4.2.5.    Rest of South America         4.3.    Asia Pacific                4.3.1.    China                4.3.2.    India                4.3.3.    Japan                4.3.4.    South Korea                4.3.5.    Rest of Asia Pacific         4.4.    Europe                4.4.1.    The UK                 4.4.2.    Germany                4.4.3.    Italy                4.4.4.    France                4.4.5.    Spain                4.4.6.    Rest of Europe         4.5.    The Middle East                4.5.1.    Turkey                4.5.2.    UAE                4.5.3.    Saudi Arabia                4.5.4.    Rest of the Middle East         4.6.    Africa                4.6.1.    Egypt                4.6.2.    South Africa                4.6.3.    Rest of Africa  5.       Value Chain Analysis of the Global Prostate Cancer Devices Market  6.       Porter Five Forces Analysis         6.1.    Threats of New Entrants         6.2.    Threats of Substitutes         6.3.    Bargaining Power of Buyers         6.4.    Bargaining Power of Suppliers         6.5.    Competition in the Industry  7.       Trends, Drivers and Challenges Analysis         7.1.    Market Trends         7.1.1.    Market Trend 1         7.1.2.    Market Trend 2         7.1.3.    Market Trend 3         7.2.    Market Drivers         7.2.1.    Market Driver 1         7.2.2.    Market Driver 2         7.2.3.    Market Driver 3         7.3.    Market Challenges         7.3.1.    Market Challenge 1         7.3.2.    Market Challenge 2         7.3.3.    Market Challenge 3  8.       Opportunities Analysis         8.1.    Market Opportunity 1         8.2.    Market Opportunity 2         8.3.    Market Opportunity 3  9.       Competitive Landscape         9.1.    Intuitive Surgical, Inc.         9.2.    Varian Medical Systems, Inc.         9.3.    Elekta GmbH         9.4.    Accuray Inc.         9.5.    HealthTronics, Inc.         9.6.    Company 6         9.7.    Company 7         9.8.    Company 8         9.9.    Company 9         9.10.  Company 10

Know the research methodology. 

Prostate Cancer Devices Market – FAQs 

1.  What is the current size of the prostate cancer devices market? 

Ans. In 2024, the prostate cancer devices market size is USD 4,957.58 Mn. 

2.  Who are the major vendors in the prostate cancer devices market?  

Ans. The major vendors in the prostate cancer devices market are Intuitive Surgical, Inc.; Varian Medical Systems, Inc.; Elekta GmbH; Accuray Inc.; HealthTronics, Inc. 

3.  Which segments are covered under the prostate cancer devices market segments analysis?  

Ans. The prostate cancer devices market report offers in-depth insights into Type, End User, and Geography.